Australia's 4DMedical extends climb as CT:VQ scans secure US reimbursement
** Shares of 4DMedical 4DX.AX rise as much as 26.4% to A$1.46, their highest level since November 23, 2021 ** 4DMedical stock extends gains to a second straight day after co said its CT:VQ scans becomes eligible for U.S. Medicare reimbursements ** Stock top gainer in the ASX All Ordinaries Index .AORD ** About 13.4 million shares change hand, 2.9 times their 30-day average ** Stock up 185% this year, including the day's move (Reporting by John Biju in Bengaluru) ((John.Biju@thomsonreuters.com;))
Recent news on 4DMedical
See all newsBrief: 4DMedical Appoints Julian Sutton As Executive Chair
Brief: 4Dmedical Ltd Says US Bill Directs VA To Adopt 4D Lung Imaging
Australia's 4DMedical rises after US lawmakers introduce VA pilot programme bill
Brief: 4Dmedical Seeks Trading Halt
Brief: 4Dmedical Receives TGA Approval For CTVQ In Australia